Colitis/Crohn’s
- Cannabidiol in inflammatory bowel diseases: a brief overview (PubMed)
- Cannabis finds its way into treatment of Crohn’s disease (PubMed)
- Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis (PubMed)
- Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis (PubMed)
- The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (PubMed)
- Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice (PubMed)
- Cannabinoids and the gut: New developments and emerging concepts (PubMed)
- Endocannabinoids and the gastrointestinal tract (PubMed)
- Cannabinoids and gastrointestinal motility: Animal and human studies (PubMed)
- Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis(O’Shaughnessy’s)
- Cannabis Alleviates Symptoms Of Crohn’s Disease (O’Shaughnessy’s)
- Cannabis Finds Its Way into Treatment of Crohn’s Disease (Institute of Experimental and Clinical Pharmacology)
- Cannabis Induces a Clinical Response in Patients With Crohn’s Disease: A Prospective Placebo-Controlled Study (Clinical Gastroenterology and Hepatology)
- Treatment of Crohn’s Disease with Cannabis: An Observational Study (Institute of Gastroenterology and Hepatology)